Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 13 studies | 56% ± 19% | |
oligodendrocyte precursor cell | 12 studies | 39% ± 11% | |
pericyte | 11 studies | 34% ± 19% | |
GABAergic neuron | 10 studies | 56% ± 22% | |
fibroblast | 9 studies | 25% ± 8% | |
neuron | 7 studies | 43% ± 19% | |
endothelial cell | 6 studies | 36% ± 15% | |
interneuron | 6 studies | 55% ± 23% | |
retinal ganglion cell | 6 studies | 51% ± 15% | |
retinal bipolar neuron | 5 studies | 71% ± 22% | |
astrocyte | 4 studies | 33% ± 22% | |
granule cell | 4 studies | 51% ± 9% | |
retina horizontal cell | 4 studies | 32% ± 14% | |
OFF-bipolar cell | 4 studies | 61% ± 22% | |
ON-bipolar cell | 4 studies | 72% ± 28% | |
smooth muscle cell | 4 studies | 20% ± 3% | |
GABAergic interneuron | 3 studies | 60% ± 0% | |
progenitor cell | 3 studies | 37% ± 23% | |
amacrine cell | 3 studies | 39% ± 18% | |
GABAergic amacrine cell | 3 studies | 41% ± 11% | |
glycinergic amacrine cell | 3 studies | 36% ± 16% | |
rod bipolar cell | 3 studies | 91% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 3262.20 | 2542 / 2642 | 83% | 8.02 | 588 / 705 |
kidney | 90% | 451.71 | 80 / 89 | 63% | 2.47 | 572 / 901 |
lung | 99% | 713.35 | 570 / 578 | 38% | 1.23 | 441 / 1155 |
bladder | 95% | 929.33 | 20 / 21 | 15% | 0.65 | 78 / 504 |
thymus | 86% | 299.47 | 563 / 653 | 24% | 0.52 | 147 / 605 |
prostate | 66% | 278.24 | 162 / 245 | 43% | 1.28 | 216 / 502 |
blood vessel | 89% | 481.13 | 1193 / 1335 | 0% | 0 | 0 / 0 |
uterus | 62% | 230.21 | 105 / 170 | 14% | 0.58 | 66 / 459 |
heart | 72% | 387.02 | 620 / 861 | 0% | 0 | 0 / 0 |
ovary | 62% | 244.84 | 111 / 180 | 8% | 0.16 | 34 / 430 |
breast | 30% | 87.01 | 139 / 459 | 35% | 0.75 | 395 / 1118 |
pancreas | 0% | 0.58 | 1 / 328 | 57% | 1.27 | 102 / 178 |
esophagus | 32% | 101.35 | 460 / 1445 | 24% | 0.49 | 44 / 183 |
stomach | 32% | 176.15 | 114 / 359 | 21% | 0.41 | 59 / 286 |
adipose | 51% | 160.42 | 617 / 1204 | 0% | 0 | 0 / 0 |
intestine | 38% | 122.03 | 367 / 966 | 10% | 0.22 | 55 / 527 |
skin | 21% | 69.19 | 381 / 1809 | 15% | 0.53 | 70 / 472 |
spleen | 26% | 72.09 | 63 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 3% | 8.70 | 9 / 258 | 22% | 1.46 | 51 / 230 |
eye | 0% | 0 | 0 / 0 | 25% | 0.62 | 20 / 80 |
liver | 11% | 28.01 | 25 / 226 | 13% | 0.32 | 52 / 406 |
peripheral blood | 12% | 45.70 | 111 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
muscle | 0% | 0.56 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | DOK6 |
Protein name | Docking protein 6 Docking protein 6 (Downstream of tyrosine kinase 6) |
Synonyms | DOK5L |
Description | FUNCTION: DOK proteins are enzymatically inert adaptor or scaffolding proteins. They provide a docking platform for the assembly of multimolecular signaling complexes. DOK6 promotes Ret-mediated neurite growth. May have a role in brain development and/or maintenance. . |
Accessions | Q6PKX4 J3KTH4 ENST00000582992.1 ENST00000382713.10 |